Sporanox



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 23.3%
Onychomycosis 13.9%
Product Used For Unknown Indication 9.3%
Fungal Infection 6.8%
Hypertension 5.1%
Antifungal Prophylaxis 4.6%
Febrile Neutropenia 4.5%
Bronchopulmonary Aspergillosis 4.0%
Prophylaxis 3.6%
Aspergillosis 3.1%
Pulmonary Mycosis 3.1%
Diabetes Mellitus 3.0%
Bronchopneumopathy 2.9%
Infection 2.3%
Sepsis 1.9%
Chronic Obstructive Pulmonary Disease 1.8%
Cystic Fibrosis 1.8%
Histoplasmosis 1.8%
Lung Infection 1.8%
Candidiasis 1.4%
Death 13.2%
Vomiting 8.0%
Weight Decreased 8.0%
Weight Increased 7.5%
Oedema Peripheral 6.3%
Pyrexia 5.7%
Drug Exposure During Pregnancy 5.2%
Dyspnoea 5.2%
Septic Shock 4.6%
Cardiac Failure Congestive 4.0%
Drug Interaction 4.0%
Renal Failure Acute 4.0%
Renal Impairment 3.4%
Vision Blurred 3.4%
Atrial Fibrillation 2.9%
Chest Discomfort 2.9%
Hyperbilirubinaemia 2.9%
Palpitations 2.9%
Sepsis 2.9%
Tinnitus 2.9%
Secondary
Prophylaxis 9.7%
Infection 9.3%
Onychomycosis 8.3%
Product Used For Unknown Indication 7.7%
Febrile Neutropenia 6.7%
Histoplasmosis 5.8%
Antifungal Prophylaxis 5.2%
Pulmonary Mycosis 5.2%
Bronchopneumopathy 4.7%
Pyrexia 4.7%
Chronic Obstructive Pulmonary Disease 4.5%
Drug Use For Unknown Indication 4.5%
Fungal Infection 4.2%
Sepsis 3.5%
Bronchopulmonary Aspergillosis 3.2%
Aspergillosis 3.0%
Intentional Overdose 3.0%
Lung Infection 2.5%
Diabetes Mellitus 2.3%
Vulvovaginal Candidiasis 2.2%
Respiratory Distress 13.7%
Weight Increased 8.5%
Septic Shock 7.7%
Vomiting 6.0%
Death 5.1%
Oedema 5.1%
Pericardial Effusion 5.1%
Pyrexia 5.1%
Renal Failure Acute 5.1%
Sopor 4.3%
Cardiac Failure 3.4%
Cardiac Failure Congestive 3.4%
Hyperbilirubinaemia 3.4%
Malaise 3.4%
Pancreatitis 3.4%
Plantar Fasciitis 3.4%
Sepsis 3.4%
Stomatitis 3.4%
Vulvovaginal Candidiasis 3.4%
Weight Decreased 3.4%
Concomitant
Drug Use For Unknown Indication 27.1%
Product Used For Unknown Indication 13.7%
Pain 5.3%
Non-hodgkin's Lymphoma 5.2%
Hiv Infection 4.8%
Peripheral T-cell Lymphoma Unspecified 4.0%
Prophylaxis 4.0%
Metastases To Bone 3.7%
Gastrooesophageal Reflux Disease 3.6%
Diffuse Large B-cell Lymphoma 3.2%
Crohn's Disease 3.1%
Asthma 2.9%
Diabetes Mellitus 2.9%
Osteoporosis 2.7%
Anxiety 2.6%
Bronchopneumonia 2.5%
Lung Transplant 2.3%
Multiple Myeloma 2.3%
Bronchopneumopathy 2.1%
Acute Myeloid Leukaemia 2.0%
Pyrexia 9.8%
Weight Decreased 9.0%
Urinary Tract Infection 7.5%
Sepsis 6.8%
Weight Increased 6.0%
Wound Drainage 6.0%
Psoriasis 5.3%
Therapeutic Agent Toxicity 5.3%
Vomiting 5.3%
Histoplasmosis 4.5%
Squamous Cell Carcinoma 4.5%
Death 3.8%
Phlebitis 3.8%
Transplant Rejection 3.8%
Upper Respiratory Tract Infection 3.8%
Febrile Neutropenia 3.0%
Pain In Extremity 3.0%
Pregnancy 3.0%
Renal Failure 3.0%
Renal Failure Acute 3.0%
Interacting
Product Used For Unknown Indication 46.3%
Asthma 11.4%
Atypical Mycobacterial Infection 6.5%
Cystic Fibrosis 6.5%
Cellulitis 3.3%
Essential Hypertension 3.3%
Fungal Infection 3.3%
Hypercholesterolaemia 3.3%
Onychomycosis 3.3%
Arthritis 1.6%
Aspergillus Infection 1.6%
Chronic Sinusitis 1.6%
Pseudomonas Infection 1.6%
Pulmonary Embolism 1.6%
Antibiotic Prophylaxis 0.8%
Anxiety 0.8%
Atrial Fibrillation 0.8%
Bronchopulmonary Aspergillosis Allergic 0.8%
Cerebrovascular Accident Prophylaxis 0.8%
Constipation 0.8%
Drug Interaction 28.6%
Myositis 9.5%
Scedosporium Infection 9.5%
Uveitis 9.5%
Vomiting 9.5%
International Normalised Ratio Increased 4.8%
Malignant Neoplasm Progression 4.8%
Myalgia 4.8%
Nausea 4.8%
Renal Failure 4.8%
Sinusitis 4.8%
Vision Blurred 4.8%